Vector Science and Therapeutics Corp. Signs Amended, 10-Year Manufacturing and Testing Agreement with LyoGenesis Holdings

Long-term agreement secures U.S.-based, cGMP manufacturing capacity for Vector's proprietary peptide platform, with quality testing performed by its affiliate Verlytix MEQUON, Wis., Aug. 17, 2026 /PRNewswire/ -- Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the...